Australian researchers have developed a tiny device that electrically stimulates the brain and could one day be used to treat conditions such as epilepsy and Parkinson’s disease without invasive surgery.
The outstanding commitment, dedication and teamwork of Melbourne Health staff and volunteers has been recognised at the 2018 Celebrating Excellence Awards, held tonight, Friday 23 November, at the Park Hyatt Melbourne.
The world’s first vaccine for people with coeliac disease is one step closer as phase two clinical trials get underway across Australia, led by The Royal Melbourne Hospital.
Two leading cancer researchers who are having an impact on the way Australia’s most common form of leukaemia is treated have been awarded the $50,000 Victoria Prize for Life Sciences.
The Royal Melbourne Hospital has been given $1 million to accelerate the growth of health and life sciences startups and build upon the success of the Melbourne Health Accelerator (MHx).
Researchers from the WHO Collaborating Centre for Viral Hepatitis at the Doherty Institute will lead a four year project to prevent liver cancer in people living with hepatitis.
Last night Melbourne Health’s commitment to excellence in patient care and innovation was recognised at the 2018 Department of Health and Human Services’ Victorian Public Healthcare Awards.
A six month follow up on patients enrolled in world’s largest study into blood transfusion during heart surgery has shown it’s safe and effective to restrict red cell transfusions.
